Future Pharmacology最新文献_第9页

Computational Screening of Plant-Derived Natural Products against SARS-CoV-2 Variants 抗SARS-CoV-2变异体植物源天然产物的计算筛选

Future Pharmacology Pub Date : 2022-11-19 DOI: 10.3390/futurepharmacol2040034

W. A. Ansari, Mohd Aamish Khan, Fahmina Rizvi, Kajim Ali, M. K. Hussain, M. Saquib, M. F. Khan

{"title":"Computational Screening of Plant-Derived Natural Products against SARS-CoV-2 Variants","authors":"W. A. Ansari, Mohd Aamish Khan, Fahmina Rizvi, Kajim Ali, M. K. Hussain, M. Saquib, M. F. Khan","doi":"10.3390/futurepharmacol2040034","DOIUrl":"https://doi.org/10.3390/futurepharmacol2040034","url":null,"abstract":"The present study explores the efficacy of plant-derived natural products (PDNPs) against spike glycoproteins (S-glycoprotein) of SARS-CoV-2 variants using molecular docking, ADMET, molecular dynamics (MD) simulation and density-functional theory (DFT) analysis. In all, 100 PDNPs were screened against spike glycoprotein of SARS-CoV-2 variants, namely alpha (B.1.1.17), beta (B.1.351), delta (B.1.617), gamma (P.1) and omicron (B.1.1.529). Results showed that rutin, EGCG, hesperidin, withanolide G, rosmarinic acid, diosmetin, myricetin, epicatechin and quercetin were the top hit compounds against each of the SARS-CoV-2 variants. The most active compounds, rutin, hesperidin, EGCG and rosmarinic acid gave binding scores of −10.2, −8.1, −8.9, −8.3 and −9.2 kcal/mol, against omicron, delta, alpha, beta and gamma variants, respectively. Further, the stability of docked complexes was confirmed by the analysis of molecular descriptors (RMSD, RMSF, SASA, Rg and H-bonds) in molecular dynamic simulation analysis. Moreover, the physiochemical properties and drug-likeness of the tested compounds showed that they have no toxicity or carcinogenicity and may be used as druggable targets. In addition, the DFT study revealed the higher activity of the tested compounds against the target proteins. This led us to conclude that rutin, hesperidin, EGCG and rosmarinic acid are good candidates to target the S-glycoproteins of SARS-CoV-2 variants. Further, in vivo and clinical studies needed to develop them as drug leads against existing or new SARS-CoV-2 variants are currently underway in our laboratory.","PeriodicalId":12592,"journal":{"name":"Future Pharmacology","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77160060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6

Ameliorative Effects of Beetroot Juice Supplementation on Monocrotaline-Induced Pulmonary Hypertension in Rats 补充甜菜根汁对单芥碱所致大鼠肺动脉高压的改善作用

Future Pharmacology Pub Date : 2022-11-16 DOI: 10.3390/futurepharmacol2040033

Masashi Tawa, Junya Nagano, Junpei Kitama, S. Abe, Ako Fujita, Keisuke Nakagawa, M. Ohkita

{"title":"Ameliorative Effects of Beetroot Juice Supplementation on Monocrotaline-Induced Pulmonary Hypertension in Rats","authors":"Masashi Tawa, Junya Nagano, Junpei Kitama, S. Abe, Ako Fujita, Keisuke Nakagawa, M. Ohkita","doi":"10.3390/futurepharmacol2040033","DOIUrl":"https://doi.org/10.3390/futurepharmacol2040033","url":null,"abstract":"Beetroot is a nitrate-rich vegetable with cardiovascular benefits. This study examined whether ingestion of beetroot juice (BRJ) protects against pulmonary hypertension (PH). Rats were injected subcutaneously with 60 mg/kg monocrotaline (MCT) and randomized to receive either drinking water, low-dose BRJ (BRJ-L, nitrate content: 1.4 mmol/L), or high-dose BRJ (BRJ-H, nitrate content: 3.5 mmol/L), which was started 1 week after MCT injection and continued until the end of the experiment. Four weeks after MCT injection, right ventricle (RV) hypertrophy, right ventricular systolic pressure (RVSP) elevation, and pulmonary vascular remodeling were observed. These PH symptoms were less severe in rats supplemented with BRJ-L (Fulton index, p = 0.07; RVSP, p = 0.09, pulmonary arterial medial thickening, p < 0.05), and the beneficial effects were more pronounced than those of BRJ-H supplementation. Plasma and RV nitrite and nitrate levels did not change significantly, even when BRJ-L and BRJ-H were administered. There were no differences in plasma thiobarbituric acid reactive substances (TBARS), a biomarker of oxidative stress, among the groups. BRJ-L supplementation significantly decreased RV TBARS levels compared to MCT alone (p < 0.05), whereas BRJ-H supplementation did not. These findings suggest that starting BRJ supplementation from an early stage of PH ameliorates disease severity, at least partly through the inhibition of local oxidative stress. Habitual ingestion of BRJ may be useful for the management of PH.","PeriodicalId":12592,"journal":{"name":"Future Pharmacology","volume":"118 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72959006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

A Mechanistic Insight on Phytoconstituents Delivering Hypoglycemic Activity: A Comprehensive Overview 植物成分提供降糖活性的机制:全面概述

Future Pharmacology Pub Date : 2022-11-09 DOI: 10.3390/futurepharmacol2040032

Shraddha Singh Raghav, Bhavna Kumar, N. Sethiya, A. Kaul

{"title":"A Mechanistic Insight on Phytoconstituents Delivering Hypoglycemic Activity: A Comprehensive Overview","authors":"Shraddha Singh Raghav, Bhavna Kumar, N. Sethiya, A. Kaul","doi":"10.3390/futurepharmacol2040032","DOIUrl":"https://doi.org/10.3390/futurepharmacol2040032","url":null,"abstract":"Diabetes is a long-term (chronic), challenging lifestyle (metabolic) disorder in which the body cannot regulate the amount of sugar in the blood and majorly affecting endocrine system and metabolic functions. Its complications majorly affect the neurons (as developing neuropathy), kidney (as nephropathy), and eye (as retinopathy). Diabetes also results in other associated problems, such as diabetic foot ulcers, sexual dysfunction, heart diseases etc. In the traditional medicines, the search for effective hypoglycemic agents is a continuous and challenging approach. Plant-derived bioactives, including alkaloids, phenols, glycosides, anthocyanins, flavonoids, saponins, tannins, polysaccharides, and terpenes, have been established to target cellular and molecular mechanisms involved in carbohydrate metabolism. Numerous diabetic patients select the herbal or traditional medicine system as an alternative therapeutic approach along with the mainstream anti-diabetic drugs. However, due to restrictive hurdles related to solubility and bioavailability, the bioactive compound cannot deliver the requisite effect. In this review, information is presented concerning well researched phytoconstituents established as potential hypoglycemic agents for the prevention and treatment of diabetes and its associated disorders having restricted solubility and bioavailability related issues. This information can be further utilized in future to develop several value added formulation and nutraceutical products to achieve the desired safety and efficacy for the prevention and treatment of diabetes and its related diseases.","PeriodicalId":12592,"journal":{"name":"Future Pharmacology","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79120173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Effect of Etanercept on Plasmodium yoelii MDR-Induced Liver Lipid Infiltration 依那西普对杨氏疟原虫耐多药肝脂浸润的影响

Future Pharmacology Pub Date : 2022-11-07 DOI: 10.3390/futurepharmacol2040031

B. Chauhan, Sarika Gunjan, S. K. Singh, S. Pandey, R. Tripathi

{"title":"Effect of Etanercept on Plasmodium yoelii MDR-Induced Liver Lipid Infiltration","authors":"B. Chauhan, Sarika Gunjan, S. K. Singh, S. Pandey, R. Tripathi","doi":"10.3390/futurepharmacol2040031","DOIUrl":"https://doi.org/10.3390/futurepharmacol2040031","url":null,"abstract":"The lipid is a vital metabolic and structural component of the malaria parasite. Malaria parasite-induced liver lipid deposits undergo peroxidation, which ultimately causes tissue damage and histopathological changes, which further lead to many complications. Therefore, it is essential to focus on the factors responsible for this stimulated lipid accumulation during malaria infection. In the present study, we have correlated the significant increase in serum TNF-α and liver triglyceride during Plasmodium yoelii MDR infection in mice. In order to explore the role of TNF-α in inducing lipid accumulation in the liver during malaria infection, we have used a competitive TNF-α inhibitor Etanercept, for the treatment of Plasmodium yoelii MDR (Py MDR) infected mice and found that Etanercept displayed up to a three-fold inhibition of the liver triglyceride level in Py MDR infected mice. These results were also confirmed by triglyceride specific oil red O staining of liver sections. In addition, all the treatment groups also showed inhibition in the level of serum TNF-α and the liver malondialdehyde (MDA), a byproduct of lipid peroxidation. Our study thus concludes that Etanercept significantly reduces Plasmodium-induced liver triglyceride and further saves the host liver from malaria-induced lipid infiltration and liver damage. Therefore, treatment with Etanercept, along with a standard antimalarial, may prove a better therapy for the disease.","PeriodicalId":12592,"journal":{"name":"Future Pharmacology","volume":"104 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75927102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Preventing Microbial Infections with Natural Phenolic Compounds 用天然酚类化合物预防微生物感染

Future Pharmacology Pub Date : 2022-11-02 DOI: 10.3390/futurepharmacol2040030

Kardelen Ecevit, A. Barros, Joana M. Silva, R. L. Reis

{"title":"Preventing Microbial Infections with Natural Phenolic Compounds","authors":"Kardelen Ecevit, A. Barros, Joana M. Silva, R. L. Reis","doi":"10.3390/futurepharmacol2040030","DOIUrl":"https://doi.org/10.3390/futurepharmacol2040030","url":null,"abstract":"The struggle between humans and pathogens has taken and is continuing to take countless lives every year. As the misusage of conventional antibiotics increases, the complexity associated with the resistance mechanisms of pathogens has been evolving into gradually more clever mechanisms, diminishing the effectiveness of antibiotics. Hence, there is a growing interest in discovering novel and reliable therapeutics able to struggle with the infection, circumvent the resistance and defend the natural microbiome. In this regard, nature-derived phenolic compounds are gaining considerable attention due to their potential safety and therapeutic effect. Phenolic compounds comprise numerous and widely distributed groups with different biological activities attributed mainly to their structure. Investigations have revealed that phenolic compounds from natural sources exhibit potent antimicrobial activity against various clinically relevant pathogens associated with microbial infection and sensitize multi-drug resistance strains to bactericidal or bacteriostatic antibiotics. This review outlines the current knowledge about the antimicrobial activity of phenolic compounds from various natural sources, with a particular focus on the structure-activity relationship and mechanisms of actions of each class of natural phenolic compounds, including simple phenols, phenolic acids, coumarin, flavonoids, tannins, stilbenes, lignans, quinones, and curcuminoids.","PeriodicalId":12592,"journal":{"name":"Future Pharmacology","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90555592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 16

Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer 巨噬细胞传递的HSV1716对三阴性乳腺癌有活性

Future Pharmacology Pub Date : 2022-10-21 DOI: 10.3390/futurepharmacol2040029

A. Kwan, Faith H N Howard, Natalie Winder, E. Atkinson, Ameera B A Jailani, Priya B. Patel, Richard Allen, P. Ottewell, G. Shaw, J. Conner, Caroline Wilson, S. Srivastava, S. Danson, Claire Lewis, Janet E Brown, M. Muthana

{"title":"Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer","authors":"A. Kwan, Faith H N Howard, Natalie Winder, E. Atkinson, Ameera B A Jailani, Priya B. Patel, Richard Allen, P. Ottewell, G. Shaw, J. Conner, Caroline Wilson, S. Srivastava, S. Danson, Claire Lewis, Janet E Brown, M. Muthana","doi":"10.3390/futurepharmacol2040029","DOIUrl":"https://doi.org/10.3390/futurepharmacol2040029","url":null,"abstract":"Oncolytic viruses (OV) promote anti-tumour responses through the initiation of immunogenic cancer cell death which activates the host’s systemic anti-tumour immunity. We have previously shown that intravenously administered HSV1716 is an effective treatment for mammary cancer. However, intravenous administration of a virus has the potential to result in neutralization and sequestration of the virus which may reduce efficacy. Here, we show that the oncolytic virus HSV1716 can be administered within a cellular carrier (macrophages). PyMT and 4T1 murine mammary cancer cell lines were implanted into immuno-competent murine models (orthotopic primary, early metastatic and brain metastasis models). HSV1716 or macrophages armed with HSV1716 (M-HSV1716) were administered intravenously, and tumour size was quantified using caliper measurement or bioluminescence imaging. Administration of M-HSV1716 led to tumour shrinkage and increased the survival of animals. Furthermore, these results were achieved with a 100-fold lower viral load, which has the potential for decreased toxicity. Our results demonstrate that M-HSV1716 is associated with activity against murine mammary cancers and provides an alternative platform for the systemic delivery of OV.","PeriodicalId":12592,"journal":{"name":"Future Pharmacology","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91144525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Critical Review of Chloroquine and Hydroxychloroquine as Potential Adjuvant Agents for Treating People with Cancer 氯喹和羟氯喹作为治疗癌症的潜在佐剂的综述

Future Pharmacology Pub Date : 2022-10-18 DOI: 10.3390/futurepharmacol2040028

A. K. Abdel-Aziz, M. K. Saadeldin, A. Salem, S. Ibrahim, S. Shouman, A. Abdel-Naim, R. Orecchia

引用次数: 3

Dendrimers-Based Drug Delivery System: A Novel Approach in Addressing Parkinson’s Disease 基于树突分子的药物传递系统:一种治疗帕金森病的新方法

Future Pharmacology Pub Date : 2022-10-10 DOI: 10.3390/futurepharmacol2040027

Michaella B. Ordonio, R. Zaki, A. Elkordy

引用次数: 2

Implications and Practical Applications of the Chemical Speciation of Iodine in the Biological Context 碘的化学形态在生物环境中的意义和实际应用

Future Pharmacology Pub Date : 2022-10-03 DOI: 10.3390/futurepharmacol2040026

A. Espino-Vázquez, Flor C. Rojas-Castro, L. M. Fajardo-Yamamoto

{"title":"Implications and Practical Applications of the Chemical Speciation of Iodine in the Biological Context","authors":"A. Espino-Vázquez, Flor C. Rojas-Castro, L. M. Fajardo-Yamamoto","doi":"10.3390/futurepharmacol2040026","DOIUrl":"https://doi.org/10.3390/futurepharmacol2040026","url":null,"abstract":"Iodine is a highly reactive element with a single natural and stable isotopic form (127I). In the biosphere, it is one of the 30 essential elements for life, and its chemical speciation defines its availability and biological activities. The most relevant chemical species are iodate (IO3−) and iodide (I−) as the major sources of iodine, with molecular iodine (I2) and hypoiodous acid (HIO) as the most reactive species, and thyroid hormones (THs) as the representative organic compounds. In human biology, THs are master regulators of metabolism, while inorganic species serve for the iodination of organic molecules and contribute to the innate immune system and the antioxidant cellular defense. Additionally, I−, I2, δ-lactone (6-IL), and α-iodohexadecanal (α-IHDA) have shown therapeutic potential in counteracting oxidative stress, cancer, and inflammation. Both inorganic and organic species have applications in the health science industry, from the manufacturing of disinfection and wound care products to supplements, medicines, and contrast media for radiography. Even after nuclear disasters, intake of high doses of iodine prevents the accumulation of radioactive iodine in the body. Conversely, the controlled production of iodine radioisotopes such as 123I, 124I, 125I, and 131I is exploited in nuclear medicine for radiotherapy and diagnostics.","PeriodicalId":12592,"journal":{"name":"Future Pharmacology","volume":"222 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74637240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Strategies for Generating Human Pluripotent Stem Cell-Derived-Organoid Culture for Disease Modeling, Drug Screening, and Regenerative Therapy 用于疾病建模、药物筛选和再生治疗的人类多能干细胞衍生类器官培养策略

Future Pharmacology Pub Date : 2022-09-05 DOI: 10.3390/futurepharmacol2030025

Zakiya Gania, Syarifah Tiara Noorintan, Ni Putu Diah Pradnya Septiari, Dhea Sandra Fitriany, Fuad Gandhi Torizal

{"title":"Strategies for Generating Human Pluripotent Stem Cell-Derived-Organoid Culture for Disease Modeling, Drug Screening, and Regenerative Therapy","authors":"Zakiya Gania, Syarifah Tiara Noorintan, Ni Putu Diah Pradnya Septiari, Dhea Sandra Fitriany, Fuad Gandhi Torizal","doi":"10.3390/futurepharmacol2030025","DOIUrl":"https://doi.org/10.3390/futurepharmacol2030025","url":null,"abstract":"Human pluripotent stem cells (hPSCs) have become a powerful tool to generate the various kinds of cell types comprising the human body. Recently, organoid technology has emerged as a platform to generate a physiologically relevant tissue-like structure from PSCs. Compared to an actual human organ, this structure more closely represents a three-dimensional microenvironment than the conventional monolayer culture system for transplantation, disease modeling, and drug development. Despite its advantages, however, the organoid culture system still has various problems related to culture methods, which have become a challenge for attempts to obtain similar physiological properties to their original tissue counterparts. Here, we discuss the current development of organoid culture methods, including the problems that may arise from the currently available culture systems, as well as a possible approach for overcoming their current limitations and improving their optimum utilization for translational application purposes.","PeriodicalId":12592,"journal":{"name":"Future Pharmacology","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82705607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5